IRZION
LIVE

Serial Number

79186760

Owner

NOVARTIS AG

Attorney

Maury M. Tepper, III

Filing Date

Mar 12, 2016

Add to watchlist:

No watchlists yet
View on USPTO

IRZION Trademark

Serial Number: 79186760 • Registration: 5097986

IRZION is a trademark filed by NOVARTIS AG on March 12, 2016. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently registered and active.

Owner Contact Info

NOVARTIS AG (7,174 trademarks)

CH-4002
BASEL , CH

Entity Type: 03

Trademark Details

Filing Date

March 12, 2016

Registration Date

December 13, 2016

Published for Opposition

September 27, 2016

Cancellation Date

April 22, 2019

Goods & Services

Anti-infectives; anti-inflammatories; antibacterial pharmaceuticals; antibiotics; anti-fungal preparations; antivirals; cardiovascular pharmaceuticals; dermatological pharmaceutical products; inhaled pharmaceutical preparations for the prevention and treatment of respiratory diseases and disorders; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations and substances for the prevention and treatment of gastrointestinal diseases; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the autoimmune system, the metabolic system, the endocrine system, the musculoskeletal system and the genitourinary system; pharmaceutical preparations for use in hematology and in tissue and organ transplantation; pharmaceutical preparations for the prevention and treatment of eye diseases and conditions; pharmaceutical preparations for the prevention and treatment of heart rhythm disorders; pharmaceutical preparations for the prevention and treatment of immune system related diseases and disorders; pharmaceutical preparations for the prevention and treatment of kidney diseases; pharmaceutical preparations for the prevention and treatment of diabetes; pharmaceutical preparations for the prevention and treatment of hypertension; pharmaceutical preparations for the prevention and treatment of skin disorders; pharmaceutical preparations for use in dermatology; pharmaceutical preparations for use in urology; pharmaceutical products for ophthalmological use; pharmaceutical products for the prevention and treatment of cancer and tumors; pharmaceutical preparations for the prevention and the treatment of allergies; pharmaceutical products for the prevention and treatment of bone diseases; pharmaceutical products for the prevention and treatment of respiratory diseases and asthma

Filing History

NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG E-MAILED
Nov 15, 2019 DENC
DEATH OF INTERNATIONAL REGISTRATION
Nov 15, 2019 DETH
NOTIFICATION PROCESSED BY IB
Oct 27, 2017 GPNX
FINAL DECISION TRANSACTION PROCESSED BY IB
Jul 8, 2017 FINV
FINAL DISPOSITION NOTICE SENT TO IB
Mar 15, 2017 FICS
FINAL DISPOSITION PROCESSED
Mar 15, 2017 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Mar 13, 2017 FICR
REGISTERED-PRINCIPAL REGISTER
Dec 13, 2016 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Sep 27, 2016 NPUB
PUBLISHED FOR OPPOSITION
Sep 27, 2016 PUBO
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Sep 7, 2016 OPNS
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Sep 7, 2016 OP2R
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Sep 7, 2016 NONP
LAW OFFICE PUBLICATION REVIEW COMPLETED
Aug 19, 2016 PREV
APPROVED FOR PUB - PRINCIPAL REGISTER
Aug 17, 2016 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Jul 25, 2016 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jul 25, 2016 CRFA
REFUSAL PROCESSED BY IB
Jul 15, 2016 RFNT
ASSIGNED TO LIE
Jul 14, 2016 ALIE
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jul 8, 2016 TROA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Jun 30, 2016 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Jun 30, 2016 REAP
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
May 27, 2016 RFCS
REFUSAL PROCESSED BY MPU
May 27, 2016 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
May 27, 2016 RFCR
NON-FINAL ACTION WRITTEN
May 26, 2016 CNRT
APPLICATION FILING RECEIPT MAILED
May 21, 2016 MAFR
ASSIGNED TO EXAMINER
May 20, 2016 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
May 17, 2016 NWOS
LIMITATION FROM ORIGINAL APPLICATION ENTERED
May 13, 2016 LIMI
SN ASSIGNED FOR SECT 66A SUBSEQ DESIG FROM IB
May 12, 2016 SDRC